- Home
- JOB vs CVM Comparison
JOB vs CVM Comparison
Compare JOB & CVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JOB | CVM |
|---|---|---|
| Founded | 1893 | 1983 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.2M | 21.4M |
| IPO Year | 2021 | 1996 |
Fundamental Metrics
Financial Performance| Metric | JOB | CVM |
|---|---|---|
| Price | $0.23 | $1.37 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 171.9K | ★ 678.1K |
| Earning Date | 05-14-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $96,504,000.00 | $264,033.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 65.45 |
| 52 Week Low | $0.17 | $0.89 |
| 52 Week High | $0.28 | $13.48 |
Technical Indicators
Market Signals| Indicator | JOB | CVM |
|---|---|---|
| Relative Strength Index (RSI) | 43.70 | 34.72 |
| Support Level | $0.22 | $0.89 |
| Resistance Level | $0.26 | $1.86 |
| Average True Range (ATR) | 0.01 | 0.15 |
| MACD | -0.00 | 0.08 |
| Stochastic Oscillator | 19.00 | 1.02 |
Price Performance
Historical ComparisonAbout JOB GEE Group Inc.
GEE Group Inc is a provider of specialized staffing solutions across the United States. The company's operating segment includes Industrial Staffing Services and Professional Staffing Services. It generates maximum revenue from the Professional Staffing Services segment. The company provides the following services, direct hire placement services, temporary professional services staffing in the fields of information technology, accounting, finance and office, engineering, and medical, and temporary light industrial staffing.
About CVM Cel-Sci Corporation
CEL-SCI Corp is a late clinical-stage biotechnology company dedicated to research and development directed at improving the treatment of cancer and other diseases by using the immune system, the body's natural defense system. The company is focused on the development of the following product candidates and technologies: 1) Multikine, an investigational Phase 3 immunotherapy under development for the potential treatment of certain head and neck cancers; 2) LEAPS (Ligand Epitope Antigen Presentation System) technology, for the potential treatment of rheumatoid arthritis.